{
    "Trade/Device Name(s)": [
        "ClearLLab 10C Panels",
        "ClearLLab 10C (T)",
        "ClearLLab 10C (B)",
        "ClearLLab 10C (M1)",
        "ClearLLab 10C (M2)",
        "Navios Flow Cytometer",
        "Navios EX Flow Cytometer",
        "ClearLLab Reagents"
    ],
    "Submitter Information": "Beckman Coulter Inc.",
    "510(k) Number": "K183592",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN160047",
        "K130373",
        "K162897"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PWD",
        "OYE"
    ],
    "Summary Letter Date": "December 20, 2018",
    "Summary Letter Received Date": "December 21, 2018",
    "Submission Date": "December 12, 2018",
    "Regulation Number(s)": [
        "21 CFR 864.7010",
        "21 CFR 864.5220"
    ],
    "Regulation Name(s)": [
        "Flow cytometric test system for hematopoietic neoplasms",
        "Automated differential cell counter"
    ],
    "Analyte Class(es)": [
        "hematology",
        "immunology"
    ],
    "Analyte(s)": [
        "Kappa",
        "Lambda",
        "CD10",
        "CD5",
        "CD200",
        "CD34",
        "CD38",
        "CD20",
        "CD19",
        "CD45",
        "TCR\u03b3\u03b4",
        "CD4",
        "CD2",
        "CD56",
        "CD3",
        "CD8",
        "CD7",
        "CD16",
        "CD13",
        "CD64",
        "CD14",
        "HLADR",
        "CD11b",
        "CD15",
        "CD123",
        "CD117",
        "CD33",
        "HLA-DR"
    ],
    "Specimen Type(s)": [
        "Peripheral whole blood",
        "Bone marrow",
        "Lymph node"
    ],
    "Specimen Container(s)": [
        "K2EDTA tube",
        "Acid Citrate Dextrose (ACD) tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Navios Flow Cytometer",
        "Navios EX Flow Cytometer"
    ],
    "Method(s)/Technology(ies)": [
        "Flow cytometry",
        "Multiparameter immunophenotyping"
    ],
    "Methodologies": [
        "Multiparameter immunophenotyping",
        "Manual sample processing",
        "Fluorescent antibody detection"
    ],
    "Submission Type(s)": [
        "Panel",
        "Reagent",
        "Analyzer",
        "Instrument",
        "Software",
        "Control",
        "Kit",
        "Beads",
        "Solution"
    ],
    "Document Summary": "FDA 510(k) summary for ClearLLab 10C panels and reagents for multiparameter immunophenotyping of hematopoietic neoplasms on Navios and Navios EX flow cytometers",
    "Indications for Use Summary": "ClearLLab 10C Panels are intended for qualitative identification of cell populations by multiparameter immunophenotyping on Navios and Navios EX flow cytometers, aiding in differential diagnosis of hematologically abnormal patients with or suspected of having hematopoietic neoplasms including chronic and acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative neoplasms, using peripheral whole blood, bone marrow, or lymph node specimens.",
    "fda_folder": "Hematology"
}